We are live on ! Find out more
IRD

Opus Genetics

34 hedge funds and large institutions have $3.21M invested in Opus Genetics in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

10% more funds holding

Funds holding: 3134 (+3)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

30% less capital invested

Capital invested by funds: $4.56M → $3.21M (-$1.35M)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.89%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
3
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change

IRD Hedge Fund Activity: Q4 2015 in Review

34 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2015, worth a combined $3.21M — down 30% from $4.56M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new IRD positions and 7 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $191K. The largest seller was Wells Fargo, exiting entirely with an estimated $205K sold.

  • 34 institutional investors held Opus Genetics (IRD) as of Q4 2015, up from 31 in Q3 2015.
  • Funds reported $3.21M of Opus Genetics stock for Q4 2015, down 30% quarter-over-quarter.
  • 10 funds opened new Opus Genetics positions in Q4 2015 and 7 closed out, a net change of +3 holders.
  • The largest Opus Genetics buyer in Q4 2015 was Renaissance Technologies, an estimated $191K added.
  • The largest Opus Genetics seller in Q4 2015 was Wells Fargo, an estimated $205K sold.

Based on aggregated 13F filings for Q4 2015.